Erythropoietin-Mimetic Peptide 17 (EMP17) is a synthetic ligand used to examine structural motifs involved in erythropoietin-receptor engagement. Its sequence supports mapping of helix-mimicking features. Researchers investigate its conformation for insights into ligand-receptor complementarity. The peptide contributes to receptor-activation modeling.
CAT No: S06027
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Emu oil in combination with other active ingredients for treating skin imperfections
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More